Physiological and pathophysiological functions of different angiotensins in the brain: REVIEW

British Journal of Pharmacology

Volumn 159, Issue 7, 2010, Pages 1392-1401

  Albrecht, Doris ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Angiotensin II; Angiotensin IV; Angiotensin (1 7); Degenerative diseases; Depression; Learning; Long term potentiation; Polymorphism; Receptors

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN II ANTAGONIST; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; NITRIC OXIDE; PROSTAGLANDIN DERIVATIVE; RENIN;

ALCOHOL ABUSE; ALZHEIMER DISEASE; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; BIPOLAR I DISORDER; BRAIN FUNCTION; CHOLINERGIC ACTIVITY; CHRONIC STRESS; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEPRESSION; DRUG EFFICACY; DRUG RECEPTOR BINDING; GENETIC ASSOCIATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MEMORY DISORDER; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TEMPORAL LOBE EPILEPSY;

EID: 77949832977     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00648.x     Document Type: Review

References (141)

1. AbdAlla S, Lother H, el Missiry A, Langer A, Sergeev P, el Faramawy Y et al. (2009a). Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J Biol Chem 284:6554 6565.
2. AbdAlla S, Lother H, el Missiry A, Sergeev P, Langer A, el Faramawy Y et al. (2009b). Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration. J Biol Chem 284:6566 6574.
3. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T et al. (2001). Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276:48623 48626.
4. Albiston AL, Fernando R, Ye S, Peck GR, Chai SY (2004). Alzheimer's, angiotensin IV and an aminopeptidase. Biol Pharm Bull 27:765 767.
5. Albrecht D (2007). Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO. Learn Mem 14:177 184.
6. Albrecht D, Broser M, Kruger H (1997a). Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats. Regul Pept 70:105 109.
7. Albrecht D, Broser M, Krüger H, Bader M (1997b). Effects of angiotensin II and IV on geniculate activity in nontransgenic and transgenic rats. Eur J Pharmacol 332:53 63.
8. Albrecht D, Nitschke T, von Bohlen und Halbach O (2000). Various effects of angiotensin II on amygdaloid neuronal activity in normotensive control and hypertensive transgenic [TGR(mREN-2)27] rats. FASEB J 14:925 931.
9. Alenina N, Xu P, Rentzsch B, Patkin EL, Bader M (2008). Genetically altered animal models for Mas and angiotensin-(1-7). Exp Physiol 93:528 537.
10. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 S209.
11. Allen AM, O'Callaghan EL, Chen D, Bassi JK (2009). Central neural regulation of cardiovascular function by angiotensin: a focus on the rostral ventrolateral medulla. Neuroendocrinology 89:361 369.
12. Ardaillou R, Chansel D (1997). Synthesis and effects of active fragments of angiotensin II. Kidney Int 52:1458 1468.
13. Arganaraz GA, Konno AC, Perosa SR, Santiago JF, Boim MA, Vidotti DB et al. (2008). The renin-angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis. Epilepsia 49:1348 1357.
14. Armando I, Seltzer A, Bregonzio C, Saavedra JM (2003). Stress and angiotensin II: novel therapeutic opportunities. Curr Drug Targets CNS Neurol Disord 2:413 419.
15. Armando I, Volpi S, Aguilera G, Saavedra JM (2007). Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res 1142:92 99.
16. Armstrong DL, Garcia EA, Ma T, Quinones B, Wayner MJ (1996). Angiotensin II blockade of long-term potentiation at the perforant path - granule cell synapse in vitro. Peptides 17:689 693.
17. Bader M, Ganten D (2008). Update on tissue renin-angiotensin systems. J Mol Med 86:615 621.
18. Baghai TC, Schule C, Zill P, Deiml T, Eser D, Zwanzger P et al. (2004). The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men. Neurosci Lett 363:38 42.
19. Bai D, Renaud LP (1998). Ang II AT1 receptors induce depolarization and inward current in rat median preoptic neurons in vitro. Am J Physiol 275:R632 R639.
20. Barnes JM, Barnes NM, Costall B, Horovitz ZP, Ironside JW, Naylor RJ et al. (1990). Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Brain Res 507:341 343.
21. Barnes JM, Barnes NM, Costall B, Coughlan J, Kelly ME, Naylor RJ et al. (1992). Angiotensin-converting enzyme inhibition, angiotensin, and cognition. J Cardiovasc Pharmacol 19 (Suppl. 6 S63 S71.
22. Basso N, Paglia N, Stella I, de Cavanagh EM, Ferder L, del Rosario Lores Arnaiz M et al. (2005). Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept 128:247 252.
23. Becker LK, Etelvino GM, Walther T, Santos RA, Campagnole-Santos MJ (2007). Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol 293:H1416 H1424.
24. von Bohlen und Halbach O, Albrecht D (1998). Visualization of specific angiotensin II binding sites in the rat limbic system. Neuropeptides 32:241 245.
25. von Bohlen und Halbach O, Albrecht D (2000). Identification of angiotensin IV binding sites in the mouse brain by a fluorescent binding study. Neuroendocrinology 72:218 223.
26. von Bohlen und Halbach O, Albrecht D (2006). The CNS renin-angiotensin system. Cell Tissue Res 326:599 616.
27. von Bohlen und Halbach O, Walther T, Bader M, Albrecht D (2000). Interaction between Mas and the angiotensin AT1 receptor in the amygdala. J Neurophysiol 83:2012 2021.
28. von Bohlen und Halbach O, Walther T, Bader M, Albrecht D (2001). Genetic deletion of angiotensin AT2 receptor leads to increased cell numbers in different brain structures of mice. Regul Pept 99:209 216.
29. Braszko JJ (2009). Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats. Eur Neuropsychopharmacol 19:85 91.
30. Braszko JJ, Walesiuk A, Wielgat P (2006). Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV. J Renin Angiotensin Aldosterone Syst 7:168 174.
31. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM (1990). Processing of angiotensin peptides by NG108-15 neuroblastoma × glioma hybrid cell line. Peptides 11:375 380.
32. Contrepas A, Walker J, Koulakoff A, Franek KJ, Qadri F, Giaume CB et al. (2009). A role of the (pro) renin receptor in neuronal cell differentiation. Am J Physiol Regul Integr Comp Physiol 297:R250 R257.
33. Costall B, Coughlan J, Horovitz ZP, Kelly ME, Naylor RJ, Tomkins DM (1989). The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Pharmacol Biochem Behav 33:573 579.
34. Crawford F, Abdullah L, Schinka J, Suo Z, Gold M, Duara R et al. (2000). Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci Lett 280:215 219.
35. Davis CJ, Kramar EA, De A, Meighan PC, Simasko SM, Wright JW et al. (2006). AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-d-aspartate dependent form of long-term potentiation. Neuroscience 137:1369 1379.
36. De Bundel D, Smolders I, Vanderheyden P, Michotte Y (2008). Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy. CNS Neurosci Ther 14:315 339.
37. Denny JB, Polan-Curtain J, Wayner MJ, Armstrong DL (1991). Angiotensin II blocks hippocampal long-term potentiation. Brain Res 567:321 324.
38. Domeney AM (1994). Angiotensin converting enzyme inhibitors as potential cognitive enhancing agents. J Psychiatry Neurosci 19:46 50.
39. Eckman EA, Adams SK, Troendle FJ, Stodola BA, Kahn MA, Fauq AH et al. (2006). Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J Biol Chem 281:30471 30478.
40. Elased KM, Cunha TS, Marcondes FK, Morris M (2008). Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice. Exp Physiol 93:665 675.
41. Ferrario CM, Barnes KL, Block CH, Brosnihan KB, Diz DI, Khosla MC et al. (1990). Pathways of angiotensin formation and function in the brain. Hypertension 15:I13 I19.
42. Fogari R, Zoppi A (2004). Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging 21:377 393.
43. Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E et al. (2003). Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens 17:781 785.
44. Ganten D, Minnich JL, Granger P, Hayduk K, Brecht HM, Barbeau A et al. (1971). Angiotensin-forming enzyme in brain tissue. Science 173:64 65.
45. Gard PR (2008). Cognitive-enhancing effects of angiotensin IV. BMC Neurosci 9 (Suppl. 2 S15.
46. Gard PR, Rusted JM (2004). Angiotensin and Alzheimer's disease: therapeutic prospects. Expert Rev Neurother 4:87 96.
47. Gard PR, Mandy A, Sutcliffe MA (1999). Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression. Biol Psychiatry 45:1030 1034.
48. Germain L, Chouinard G (1988). Treatment of recurrent unipolar major depression with captopril. Biol Psychiatry 23:637 641.
49. Grammatopoulos TN, Outeiro TF, Hyman BT, Standaert DG (2007). Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro. Biochem Biophys Res Commun 363:846 851.
50. Grobe JL, Xu D, Sigmund CD (2008). An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology (Bethesda) 23:187 193.
51. Hajjar I, Catoe H, Sixta S, Boland R, Johnson D, Hirth V et al. (2005). Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci 60:67 73.
52. Hallberg M, Nyberg F (2003). Neuropeptide conversion to bioactive fragments - an important pathway in neuromodulation. Curr Protein Pept Sci 4:31 44.
53. Hellner K, Walther T, Schubert M, Albrecht D (2005). Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci 29:427 435.
54. Hemming ML, Selkoe DJ (2005). Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 280:37644 37650.
55. Hemming ML, Selkoe DJ, Farris W (2007). Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease. Neurobiol Dis 26:273 281.
56. Hou DR, Wang Y, Zhou L, Chen K, Tian Y, Song Z et al. (2008). Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease. Chin Med J (Engl) 121:2320 2323.
57. Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I et al. (2009). Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 53:356 362.
58. Jenkins TA (2008). Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats. Neurosci Lett 444:186 189.
59. Jindra A Jr., Kvetnansky R (1982). Stress-induced activation of inactive renin. J Biol Chem 257:5997 5999.
60. Karamyan VT, Speth RC (2007). Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. Regul Pept 143:15 27.
61. Karamyan VT, Gembardt F, Rabey FM, Walther T, Speth RC (2008). Characterization of the brain-specific non-AT(1), non-AT(2) angiotensin binding site in the mouse. Eur J Pharmacol 590:87 92.
62. Kehoe PG, Katzov H, Andreasen N, Gatz M, Wilcock GK, Cairns NJ et al. (2004). Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease. Hum Genet 114:478 483.
63. Kokje RJ, Wilson WL, Brown TE, Karamyan VT, Wright JW, Speth RC (2007). Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis. Hypertension 49:1328 1335.
64. Kostenis E, Milligan G, Christopoulos A, Sanchez-Ferrer CF, Heringer-Walther S, Sexton PM et al. (2005). G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111:1806 1813.
65. Kramar EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, Wright JW (2001). The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res 897:114 121.
66. Lavoie JL, Sigmund CD (2003). Minireview: overview of the renin-angiotensin system - an endocrine and paracrine system. Endocrinology 144:2179 2183.
67. Lazartigues E, Feng Y, Lavoie JL (2007). The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases. Curr Pharm Des 13:1231 1245.
68. Lazartigues E, Sinnayah P, Augoyard G, Gharib C, Johnson AK, Davisson RL (2008). Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors. Am J Physiol Regul Integr Comp Physiol 295:R1539 R1545.
69. Lee J, Chai SY, Mendelsohn FA, Morris MJ, Allen AM (2001). Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacology 40:618 623.
70. Leiter LA, Lewanczuk RZ (2005). Of the renin-angiotensin system and reactive oxygen species type 2 diabetes and angiotensin II inhibition. Am J Hypertens 18:121 128.
71. Lenkei Z, Palkovits M, Corvol P, Llorens Cortes C (1997). Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18:383 439.
72. Liebl C, Panhuysen M, Putz B, Trumbach D, Wurst W, Deussing JM et al. (2009). Gene expression profiling following maternal deprivation: involvement of the brain renin-angiotensin system. Front Mol Neurosci 2:1 10.
73. Lippoldt A, Paul M, Fuxe K, Ganten D (1995). The brain renin-angiotensin system - molecular mechanisms of cell-to-cell interactions. Clin Exp Hypertension 17:251 266.
74. Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL (2005). Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of parkinsonism. J Neurosci Res 81:865 873.
75. Lyngso C, Erikstrup N, Hansen JL (2009). Functional interactions between 7TM receptors in the renin-angiotensin system - dimerization or crosstalk? Mol Cell Endocrinol 302:203 212.
76. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM et al. (2003). The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35:901 918.
77. McKinley MJ, Walker LL, Alexiou T, Allen AM, Campbell DJ, Di NR et al. (2008). Osmoregulatory fluid intake but not hypovolemic thirst is intact in mice lacking angiotensin. Am J Physiol Regul Integr Comp Physiol 294:R1533 R1543.
78. Maul B, Krause W, Pankow K, Becker M, Gembardt F, Alenina N et al. (2005). Central angiotensin II controls alcohol consumption via its AT1 receptor. FASEB J 19:1474 1481.
79. Maul B, von Bohlen und Halbach O, Becker A, Sterner-Kock A, Voigt JP, Siems WE et al. (2008). Impaired spatial memory and altered dendritic spine morphology in angiotensin II type 2 receptor-deficient mice. J Mol Med 86:563 571.
80. Mellick GD, Buchanan DD, McCann SJ, Davis DR, Le Couteur DG, Chan D et al. (1999). The ACE deletion polymorphism is not associated with Parkinson's disease. Eur Neurol 41:103 106.
81. Michalsen A, Wenzel RR, Mayer C, Broer M, Philipp T, Dobos GJ (2001). [Quality of life and psychosocial factors during treatment with antihypertensive drugs. A comparison of captopril and quinapril in geriatric patients]. Herz 26:468 476.
82. Moeller I, Lew RA, Mendelsohn FA, Smith AI, Brennan ME, Tetaz TJ et al. (1997). The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain. J Neurochem 68:2530 2537.
83. Monastero R, Caldarella R, Mannino M, Cefalu AB, Lopez G, Noto D et al. (2002). Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease. Neurosci Lett 335:147 149.
84. Moore R, Krstew EV, Kirchhoff J, Davisson RL, Lawrence AJ (2007). Central overexpression of angiotensin AT(1A) receptors prevents dopamine D(2) receptor regulation of alcohol consumption in mice. Alcohol Clin Exp Res 31:1128 1137.
85. Morimoto S, Sigmund CD (2002). Angiotensin mutant mice: a focus on the brain renin-angiotensin system. Neuropeptides 36:194 200.
86. Nguyen G, Contrepas A (2008). Physiology and pharmacology of the (pro)renin receptor. Curr Opin Pharmacol 8:127 132.
87. Nikolova JG, Getova DP, Nikolov FP (2000). Effects of ACE-inhibitors on learning and memory processes in rats. Folia Med (Plovdiv) 42:47 51.
88. Pauls J, Bandelow B, Ruther E, Kornhuber J (2000). Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder. J Neural Transm 107:1361 1366.
89. Pederson ES, Krishnan R, Harding JW, Wright JW (2001). A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits. Regul Pept 102:147 156.
90. Pedreanez A, Arcaya JL, Carrizo E, Mosquera J (2006). Forced swimming test increases superoxide anion positive cells and angiotensin II positive cells in the cerebrum and cerebellum of the rat. Brain Res Bull 71:18 22.
91. Phillips MI, de Oliveira EM (2008). Brain renin angiotensin in disease. J Mol Med 86:715 722.
92. Pickel VM, Chan J (1995). Colocalization of angiotensin-II and gamma-aminobutyric-acid in axon terminals in the rat subfornical organ. Neurosci Lett 193:89 92.
93. Raghavendra V, Chopra K, Kulkarni SK (2001). Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides 35:65 69.
94. Ramser J, Abidi FE, Burckle CA, Lenski C, Toriello H, Wen G et al. (2005). A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet 14:1019 1027.
95. Reagan LP, Flanagan-Cato LM, Yee DK, Ma LY, Sakai RR, Fluharty SJ (1994). Immunohistochemical mapping of angiotensin type 2 (AT2) receptors in rat brain. Brain Res 662:45 59.
96. Reardon KA, Mendelsohn FA, Chai SY, Horne MK (2000). The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease. Aust N Z J Med 30:48 53.
97. Rey P, Lopez-Real A, Sanchez-Iglesias S, Munoz A, Soto-Otero R, Labandeira-Garcia JL (2007). Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. Neurobiol Aging 28:555 567.
98. Rodriguez-Pallares J, Rey P, Parga JA, Munoz A, Guerra MJ, Labandeira-Garcia JL (2008). Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol Dis 31:58 73.
99. Saavedra JM (2005). Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25:485 512.
100. Saavedra JM, Benicky J (2007). Brain and peripheral angiotensin II play a major role in stress. Stress 10:185 193.
101. Saavedra JM, Benicky J, Zhou J (2006). Angiotensin II: multitasking in the brain. J Hypertens Suppl 24:S131 S137.
102. Santos RA, Campagnole-Santos MJ, Andrade SP (2000). Angiotensin-(1-7): an update. Regul Pept 91:45 62.
103. Santos RA, Simoes E, Silva AC, Maric C, Silva DM, Machado RP et al. (2003). Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100:8258 8263.
104. Santos EL, Reis RI, Silva RG, Shimuta SI, Pecher C, Bascands JL et al. (2007). Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene. Regul Pept 141:159 167.
105. Savaskan E, Hock C, Olivieri G, Bruttel S, Rosenberg C, Hulette C et al. (2001). Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging 22:541 546.
106. Sayeski PP, Ali MS, Semeniuk DJ, Doan TN, Bernstein KE (1998). Angiotensin II signal transduction pathways. Regul Pept 78:19 29.
107. Scheen AJ (2004). Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system. Drugs 64:2537 2565.
108. Segman RH, Shapira Y, Modai I, Hamdan A, Zislin J, Heresco-Levy U et al. (2002). Angiotensin converting enzyme gene insertion/deletion polymorphism: case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia. Am J Med Genet 114:310 314.
109. Shan Z, Cuadra AE, Sumners C, Raizada MK (2008). Characterization of a functional (pro)renin receptor in rat brain neurons. Exp Physiol 93:701 708.
110. Shenoy UV, Richards EM, Huang XC, Sumners C (1999). Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain. Endocrinology 140:500 509.
111. Sleegers K, den Heijer T, van Dijk EJ, Hofman A, Bertoli-Avella AM, Koudstaal PJ et al. (2005). ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala. Neurobiol Aging 26:1153 1159.
112. Sommer WH, Saavedra JM (2008). Targeting brain angiotensin and corticotrophin-releasing hormone systems interaction for the treatment of mood and alcohol use disorders. J Mol Med 86:723 728.
113. Sparks DL, Hunsaker JC, III., Amouyel P, Malafosse A, Bellivier F, Leboyer M et al. (2009). Angiotensin I-converting enzyme I/D polymorphism and suicidal behaviors. Am J Med Genet B Neuropsychiatr Genet 150B:290 294.
114. Stewart JA, Kampman O, Huuhka M, Anttila S, Huuhka K, Lehtimaki T et al. (2009). ACE polymorphism and response to electroconvulsive therapy in major depression. Neurosci Lett 458:122 125.
115. Stragier B, Clinckers R, Meurs A, De BD, Sarre S, Ebinger G et al. (2006). Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats. J Neurochem 98:1100 1113.
116. Stragier B, De BD, Sarre S, Smolders I, Vauquelin G, Dupont A et al. (2008). Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review. Heart Fail Rev 13:321 337.
117. Sumners C, Fleegal MA, Zhu M (2002). Angiotensin AT1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 29:483 490.
118. Taylor A, Ezquerra M, Bagri G, Yip A, Goumidi L, Cottel D et al. (2001). Alzheimer disease is not associated with polymorphisms in the angiotensinogen and renin genes. Am J Med Genet 105:761 764.
119. Tchekalarova J, Albrecht D (2007). Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels. Neurosci Lett 415:68 72.
120. Tchekalarova J, Georgiev V (1999). Adenosine-angiotensin II interactions in pentylenetetrazol seizure threshold in mice. J Physiol Paris 93:191 197.
121. Tchekalarova J, Georgiev V (2005). Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility? Life Sci 76:955 970.
122. Tchekalarova J, Kambourova T, Georgiev V (2001). Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors. Brain Res Bull 56:87 91.
123. Tian J, Shi J, Bailey K, Harris JM, Pritchard A, Lambert JC et al. (2004). A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease. Neurosci Lett 354:103 106.
124. Tom B, Dendorfer A, Jan Danser AH (2003). Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? Int J Biochem Cell Biol 35:792 801.
125. Tracy HA Jr., Wayner MJ, Armstrong DL (1997). Losartan improves the performance of ethanol-intoxicated rats in an eight-arm radial maze. Alcohol 14:511 517.
126. Vanderheyden PM (2009). From angiotensin IV binding site to AT4 receptor. Mol Cell Endocrinol 302:159 166.
127. Vauquelin G, Michotte Y, Smolders I, Sarre S, Ebinger G, Dupont A et al. (2002). Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. J Renin Angiotensin Aldosterone Syst 3:195 204.
128. Vicario A, Martinez CD, Baretto D, Diaz CA, Nicolosi L (2005). Hypertension and cognitive decline: impact on executive function. J Clin Hypertens (Greenwich) 7:598 604.
129. Wakutani Y, Kowa H, Kusumi M, Yamagata K, Wada-Isoe K, Adachi Y et al. (2002). Genetic analysis of vascular factors in Alzheimer's disease. Ann N Y Acad Sci 977:232 238.
130. Walther T, Balschun D, Voigt JP, Fink H, Zuschratter W, Birchmeier C et al. (1998). Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene. J Biol Chem 273:11867 11873.
131. Walther T, Albrecht D, Becker M, Schubert M, Kouznetsova E, Wiesner B et al. (2009). Improved learning and memory in aged mice deficient in amyloid beta-degrading neutral endopeptidase. Plos ONE 4:e4590.
132. Wayner MJ, Armstrong DL, Polan-Curtain JL, Denny JB (1993). Role of angiotensin II and AT1 receptors in hippocampal LTP. Pharmacol Biochem Behav 45:455 464.
133. Wayner MJ, Polan Curtain JL, Chiu SC, Armstrong DL (1994). Losartan reduces ethanol intoxication in the rat. Alcohol 11:343 346.
134. Wayner MJ, Armstrong DL, Phelix CF, Wright JW, Harding JW (2001). Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides 22:1403 1414.
135. Wilson WL, Munn C, Ross RC, Harding JW, Wright JW (2009). The role of the AT4 and cholinergic systems in the nucleus basalis magnocellularis (NBM): effects on spatial memory. Brain Res 1272:25 31.
136. Wright JW, Harding JW (2008). The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease. J Renin Angiotensin Aldosterone Syst 9:226 237.
137. Wright JW, Kramar EA, Myers ED, Davis CJ, Harding JW (2003). Ethanol-induced suppression of LTP can be attenuated with an angiotensin IV analog. Regul Pept 113:49 56.
138. Wright JW, Yamamoto BJ, Harding JW (2008). Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Prog Neurobiol 84:157 181.
139. Yang G, Wan Y, Zhu YL (1996). Angiotensin II - an important stress hormone. Biol Signals 5:1 8.
140. Yang JD, Feng G, Zhang J, Lin ZX, Shen T, Breen G et al. (2000). Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han Chinese. Neurosci Lett 295:41 44.
141. Zhuo J, Moeller I, Jenkins T, Chai SY, Allen AM, Ohishi M et al. (1998). Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors. J Hypertens 16:2027 2037.